Source comparison
Melanotan-2 Tanning Protocol Dosage Timing: Loading vs Maintenance Phases
Standard research protocols distinguish between loading and maintenance phases based on the time required to saturate MC1R binding sites and establish baseline melanin production. The loading phase serves a specific pharmacological purpose: achieving steady-st
This comparison does not assign a generated winner or score.
- Standard research protocols distinguish between loading and maintenance phases based on the time required to saturate MC1R binding sites and establish baseline melanin production. The loading phase serves a specific pharmacological purpose: achieving steady-state receptor occupancy so melanogenesis continues at a consistent rate rather than cycling with each injection.
- Loading Phase Protocol (Days 1–10):Daily subcutaneous injections of 250–500mcg administered 2–4 hours before planned UV exposure. Subjects with Fitzpatrick skin types I–II typically start at 250mcg to assess tolerance (nausea and facial flushing are common at higher initial doses), while types III–IV may begin at 500mcg. UV exposure should be structured: 10–15 minutes of unprotected midday sun exposure (UV index 6+) or equivalent controlled UV-B lamp exposure at 0.3–0.5 MED (minimal erythemal dose). Injecting at 10 AM with UV exposure at 1 PM places peak plasma MT-2 levels (4–6 hours post-injection) concurrent with tyrosinase activation from UV stimulus.
- Maintenance Phase Protocol (Day 11 onward):Once baseline tan is established (visibly darker skin tone sustained 48+ hours without UV re-exposure), frequency reduces to 2–3 times weekly at 250–500mcg per injection. Maintenance timing should still coordinate with planned UV exposure. Injecting only on days when UV stimulus will occur within 12–24 hours. Subjects who inject randomly throughout the week without corresponding UV exposure report tan fading within 2–3 weeks despite continued peptide use, consistent with melanin degradation rates exceeding synthesis rates without sustained UV stimulus.
- The procedural error we observe repeatedly: subjects front-load injections (daily dosing) but inconsistently expose themselves to UV light, expecting the peptide alone to drive pigmentation. MT-2 without UV produces minimal visible tanning because melanin synthesis requires both MC1R activation (from MT-2) and tyrosinase substrate availability (from UV-triggered oxidative stress). The melanocortin receptor binding is necessary but not sufficient. UV exposure completes the pathway.